Ignite Creation Date:
2024-05-06 @ 8:51 AM
Last Modification Date:
2024-10-26 @ 12:05 PM
Study NCT ID:
NCT02831673
Status:
COMPLETED
Last Update Posted:
2023-08-24
First Post:
2016-07-08
Brief Title:
An Efficacy Safety and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus TenofovirEmtricitabine in Treatment naïve HIV Infected Subjects Gemini 1
Sponsor:
ViiV Healthcare
Organization:
ViiV Healthcare
Organization Data
Organization:
ViiV Healthcare
Class:
INDUSTRY
Study ID:
204861
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ViiV Healthcare
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |
| PPD | INDUSTRY |